Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC). Background: HER2-targeted agents markedly improve ...
Corrected area under serum PSA curve as a predictor of survival after chemotherapy for hormone-refractory prostate cancer (HRPC) patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback